BIOMAT Database Logo BIOMAT Database Logo

[Effect of atenolol on the excretion of catecholamines and their metabolites and dihydroxyphenylalanine (DOPA) in patients with essential hypertension]. 1982

B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001262 Atenolol A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. ICI-66082,Tenormin,Tenormine,ICI 66082,ICI66082

Related Publications

B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
[Effect of hypotensive treatment on the excretion of catecholamines and their metabolites in patients with essential hypertension].
January 1979, Kardiologia polska,
B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
[The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
January 1973, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
[Effect of labetalol on the excretion of catecholamines and their metabolites in primary hypertension].
August 1981, Polski tygodnik lekarski (Warsaw, Poland : 1960),
B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
[Effect of submaximal muscular exercise of short duration on urinary excretion of catecholamines, DOPA and their metabolites].
December 1978, Archives internationales de physiologie et de biochimie,
B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
[Effect of sympathomimetics on the excretion of catecholamines and their metabolites].
March 1986, Pneumonologia polska,
B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
[Excretion of catecholamines and their precursor DOPA in patients with meningococcal infection].
January 1976, Terapevticheskii arkhiv,
B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
3,4-dihydroxyphenylalanine (DOPA) excretion in patients with malignant melanoma.
October 1962, Lancet (London, England),
B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
Urinary excretion of catecholamines and their principal metabolites in arterial hypertension.
February 1972, Vrachebnoe delo,
B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
[Urinary excretion of catecholamines and their metabolites in labile arterial hypertension].
January 1983, Acta medica portuguesa,
B Wocial, and W Januszewicz, and M Sznajderman, and T Feltynowski
[ON THE PRESENCE OF CATECHOLAMINES AND 3,4-DIHYDROXYPHENYLALANINE (DOPA) IN THE EYE].
May 1964, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
Copied contents to your clipboard!